CD274 and neoplasm: However, PD‐L1 expression in tissue as a predictive biomarker has limitations: range of different antibodies used in clinical trials, different positive thresholds, heterogeneity in PD‐L1 staining in the tumor, insufficient tumor tissue, among others [66].